- Home
- HOFT vs CNTX Comparison
HOFT vs CNTX Comparison
Compare HOFT & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOFT
- CNTX
- Stock Information
- Founded
- HOFT 1924
- CNTX 2015
- Country
- HOFT United States
- CNTX United States
- Employees
- HOFT N/A
- CNTX N/A
- Industry
- HOFT Home Furnishings
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- HOFT Consumer Discretionary
- CNTX Health Care
- Exchange
- HOFT Nasdaq
- CNTX Nasdaq
- Market Cap
- HOFT 102.9M
- CNTX 102.9M
- IPO Year
- HOFT 1999
- CNTX 2021
- Fundamental
- Price
- HOFT $9.91
- CNTX $1.16
- Analyst Decision
- HOFT
- CNTX Strong Buy
- Analyst Count
- HOFT 0
- CNTX 7
- Target Price
- HOFT N/A
- CNTX $5.40
- AVG Volume (30 Days)
- HOFT 32.7K
- CNTX 410.4K
- Earning Date
- HOFT 12-04-2025
- CNTX 11-05-2025
- Dividend Yield
- HOFT 9.30%
- CNTX N/A
- EPS Growth
- HOFT N/A
- CNTX N/A
- EPS
- HOFT N/A
- CNTX N/A
- Revenue
- HOFT $376,278,000.00
- CNTX N/A
- Revenue This Year
- HOFT N/A
- CNTX N/A
- Revenue Next Year
- HOFT $15.15
- CNTX N/A
- P/E Ratio
- HOFT N/A
- CNTX N/A
- Revenue Growth
- HOFT N/A
- CNTX N/A
- 52 Week Low
- HOFT $7.34
- CNTX $0.49
- 52 Week High
- HOFT $19.79
- CNTX $2.10
- Technical
- Relative Strength Index (RSI)
- HOFT 62.90
- CNTX 52.21
- Support Level
- HOFT $8.97
- CNTX $1.04
- Resistance Level
- HOFT $9.44
- CNTX $1.22
- Average True Range (ATR)
- HOFT 0.35
- CNTX 0.08
- MACD
- HOFT 0.15
- CNTX -0.01
- Stochastic Oscillator
- HOFT 99.19
- CNTX 45.90
About HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.